{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T08:15:41Z","timestamp":1759133741836},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2009,12,28]],"date-time":"2009-12-28T00:00:00Z","timestamp":1261958400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Strahlenther Onkol"],"published-print":{"date-parts":[[2010,1]]},"DOI":"10.1007\/s00066-009-2037-1","type":"journal-article","created":{"date-parts":[[2010,1,14]],"date-time":"2010-01-14T23:00:51Z","timestamp":1263510051000},"page":"30-35","source":"Crossref","is-referenced-by-count":26,"title":["High-Grade Acute Organ Toxicity During Preoperative Radiochemotherapy as Positive Predictor for Complete Histopathologic Tumor Regression in Multimodal Treatment of Locally Advanced Rectal Cancer*"],"prefix":"10.1007","volume":"186","author":[{"given":"Hendrik Andreas","family":"Wolff","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jochen","family":"Gaedcke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Klaus","family":"Jung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert Michael","family":"Hermann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hilka","family":"Rothe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Markus","family":"Schirmer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Torsten","family":"Liersch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Markus Karl Alfred","family":"Herrmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Steffen","family":"Hennies","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Margret","family":"Rave-Fr\u00e4nk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Clemens Friedrich","family":"Hess","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hans","family":"Christiansen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2009,12,28]]},"reference":[{"key":"2037_CR1","doi-asserted-by":"publisher","first-page":"3471","DOI":"10.1245\/s10434-008-0149-y","volume":"15","author":"D. Beddy","year":"2008","unstructured":"Beddy D, Hyland JM, Winter DC, et al. A simplified tumor regression grade correlates with survival in locally advanced rectal carcinoma treated with neoadjuvant chemoradiotherapy. Ann Surg Oncol 2008;15:3471\u20137.","journal-title":"Ann Surg Oncol"},{"key":"2037_CR2","doi-asserted-by":"publisher","first-page":"S73","DOI":"10.1016\/j.ijrobp.2005.07.126","volume":"63","author":"J.A. Bonner","year":"2005","unstructured":"Bonner JA, Harari P, Giralt J, et al. The relationship of cetuximab-induced rash and survival in patients with head and neck cancer treated with radiotherapy and cetuximab. Int J Radiat Oncol Biol Phys 2005;63:S73.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2037_CR3","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1016\/j.ijrobp.2008.01.007","volume":"71","author":"K. Borgmann","year":"2008","unstructured":"Borgmann K, Hoeller U, Nowack S, et al. Individual radiosensitivity measured with lymphocytes may predict the risk of acute reaction after radiotherapy. Int J Radiat Oncol Biol Phys 2008;71:256\u201364.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2037_CR4","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1016\/S1278-3218(98)80104-2","volume":"2","author":"J. Chavaudra","year":"1998","unstructured":"Chavaudra J. Last ICRU recommendations for the prescription, recording and reporting of external bean therapy. Cancer Radiother 1998;2:607\u201314.","journal-title":"Cancer Radiother"},{"key":"2037_CR5","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1002\/hed.20030","volume":"26","author":"H. Christiansen","year":"2004","unstructured":"Christiansen H, Hermann RM, Hille A, et al. Concomitant radiochemotherapy in primary inoperable advanced head and neck cancer with 5-fluorouracil and mitomycin-C. Head Neck 2004;26:845\u201353.","journal-title":"Head Neck"},{"key":"2037_CR6","first-page":"39","volume":"16","author":"C.H. Crane","year":"2002","unstructured":"Crane CH, Janjan NA, Mason K, et al. Preoperative chemoradiation for locally advanced rectal cancer: emerging treatment strategies. Oncology (Williston Park) 2002;16:39\u201344.","journal-title":"Oncology (Williston Park)"},{"key":"2037_CR7","doi-asserted-by":"publisher","first-page":"1143","DOI":"10.1016\/S1470-2045(08)70259-6","volume":"9","author":"J. Cuzick","year":"2008","unstructured":"Cuzick J, Sestak I, Cella D, et al. Treatment-emergent endocrine symptoms and the risk of breast cancer recurrence: a retrospective analysis of the ATAC trial. Lancet Oncol 2008;9:1143\u20138.","journal-title":"Lancet Oncol"},{"key":"2037_CR8","doi-asserted-by":"publisher","first-page":"409","DOI":"10.3109\/02841869409098437","volume":"33","author":"O. Dahl","year":"1994","unstructured":"Dahl O, Horn A, Mella O. Do acute side-effects during radiotherapy predict tumour response in rectal carcinoma? Acta Oncol 1994;33:409\u201313.","journal-title":"Acta Oncol"},{"key":"2037_CR9","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/S0167-8140(03)00198-1","volume":"68","author":"T. Daly","year":"2003","unstructured":"Daly T, Poulsen MG, Denham JW, et al. The effect of anaemia on efficacy and normal tissue toxicity following radiotherapy for locally advanced squamous cell carcinoma of the head and neck. Radiother Oncol 2003;68:113\u201322.","journal-title":"Radiother Oncol"},{"key":"2037_CR10","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1007\/s00066-008-1764-z","volume":"184","author":"K Dellas","year":"2008","unstructured":"Dellas K, Bache M, Pigorsch SU, et al. Prognostic impact of HIF-1\u03b1 expression in patients with definitive radiotherapy for cervical cancer. Strahlenther Onkol 2008;184:169\u201374.","journal-title":"Strahlenther Onkol"},{"key":"2037_CR11","unstructured":"Deutsche Gesellschaft der epidemiologischen Krebsregister. Broschure \u201eKrebs in Deutschland\u201c, 5. Aufl. Berlin: Robert-Koch-Institut, 2006."},{"key":"2037_CR12","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1007\/s001060050635","volume":"48","author":"A. Dietz","year":"2000","unstructured":"Dietz A, Rudat V, Conradt C, et al. Prognostic value of hemoglobin level for primary radiochemotherapy of head-neck carcinomas. HNO 2000;48:655\u201364.","journal-title":"HNO"},{"key":"2037_CR13","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1007\/s00066-008-1725-6","volume":"184","author":"H.T. Eich","year":"2008","unstructured":"Eich HT, Loschcke M, Scheer M, et al. Neoadjuvant radiochemotherapy and radical resection for advanced squamous cell carcinoma of the oral cavity. Outcome of 134 patients. Strahlenther Onkol 2008;184:23\u20139.","journal-title":"Strahlenther Onkol"},{"key":"2037_CR14","doi-asserted-by":"publisher","first-page":"2077","DOI":"10.1200\/JCO.1995.13.8.2077","volume":"13","author":"D.A. Fein","year":"1995","unstructured":"Fein DA, Lee WR, Hanlon AL, et al. Pretreatment hemoglobin level influences local control and survival of T1\u2013T2 squamous cell carcinomas of the glottic larynx. J Clin Oncol 1995;13:2077\u201383.","journal-title":"J Clin Oncol"},{"key":"2037_CR15","doi-asserted-by":"publisher","first-page":"1075","DOI":"10.1007\/BF02236553","volume":"43","author":"M. Gavioli","year":"2000","unstructured":"Gavioli M, Bagni A, Piccagli I, et al. Usefulness of endorectal ultrasound after preoperative radiotherapy in rectal cancer: comparison between sonographic and histopathologic changes. Dis Colon Rectum 2000;43:1075\u201383.","journal-title":"Dis Colon Rectum"},{"key":"2037_CR16","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1007\/s10350-007-9080-8","volume":"51","author":"R. Glynne-Jones","year":"2008","unstructured":"Glynne-Jones R, Wallace M, Livingstone JI, et al. Complete clinical response after preoperative chemoradiation in rectal cancer: is a \u201cwait and see\u201d policy justified? Dis Colon Rectum 2008;51:10\u20139, discussion 9\u201320.","journal-title":"Dis Colon Rectum"},{"key":"2037_CR17","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1017\/S0022215100145323","volume":"113","author":"D.G. Grant","year":"1999","unstructured":"Grant DG, Hussain A, Hurman D. Pre-treatment anaemia alters outcome in early squamous cell carcinoma of the larynx treated by radical radiotherapy. J Laryngol Otol 1999;113:829\u201333.","journal-title":"J Laryngol Otol"},{"key":"2037_CR18","first-page":"31","volume":"7","author":"A. Haydaroglu","year":"2002","unstructured":"Haydaroglu A, Yurut V, Arican A, et al. The impact of the haemoglobin level on the response to radiotherapy. J BUON 2002;7:31\u20134.","journal-title":"J BUON"},{"key":"2037_CR19","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1007\/s000660050032","volume":"175","author":"T. Herrmann","year":"1999","unstructured":"Herrmann T, Petersen S, Hellmich G, et al. Delayed toxicity of brief preoperative irradiation and risk-adjusted postoperative radiotherapy of operative rectal carcinoma. Results of a randomized prospective study. Strahlenther Onkol 1999;175:430\u20136.","journal-title":"Strahlenther Onkol"},{"key":"2037_CR20","doi-asserted-by":"publisher","first-page":"1647","DOI":"10.1200\/JCO.2005.05.4825","volume":"25","author":"I.D. Nagtegaal","year":"2007","unstructured":"Nagtegaal ID, Gosens MJ, Marijnen CA, et al. Combinations of tumor and treatment parameters are more discriminative for prognosis than the present TNM system in rectal cancer. J Clin Oncol 2007;25:1647\u201350.","journal-title":"J Clin Oncol"},{"key":"2037_CR21","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1007\/s00432-004-0633-0","volume":"131","author":"O. Pradier","year":"2005","unstructured":"Pradier O, Lederer K, Hille A, et al. Concurrent low-dose cisplatin and thoracic radiotherapy in patients with inoperable stage III non-small cell lung cancer: a phase II trial with special reference to the hemoglobin level as prognostic parameter. J Cancer Res Clin Oncol 2005;131:261\u20139.","journal-title":"J Cancer Res Clin Oncol"},{"key":"2037_CR22","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1007\/s00066-008-1825-3","volume":"184","author":"D. Rades","year":"2008","unstructured":"Rades D, Stoehr M, Meyners T, et al. Evaluation of prognostic factors and two radiation techniques in patients treated with surgery followed by radio(chemo)therapy or definitive radio(chemo)therapy for locally advanced head-and-neck cancer. Strahlenther Onkol 2008;184:198\u2013205.","journal-title":"Strahlenther Onkol"},{"key":"2037_CR23","doi-asserted-by":"publisher","first-page":"8688","DOI":"10.1200\/JCO.2005.02.1329","volume":"23","author":"C. R\u00f6del","year":"2005","unstructured":"R\u00f6del C, Martus P, Papadoupolos T, et al. Prognostic significance of tumor regression after preoperative chemoradiotherapy for rectal cancer. J Clin Oncol 2005;23:8688\u201396.","journal-title":"J Clin Oncol"},{"key":"2037_CR24","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1007\/s00066-007-9000-9","volume":"183","author":"C. R\u00f6del","year":"2007","unstructured":"R\u00f6del C, Sauer R. Integration of novel agents into combined-modality treatment for rectal cancer patients. Strahlenther Onkol 2007;183:227\u201335.","journal-title":"Strahlenther Onkol"},{"key":"2037_CR25","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1007\/s00384-007-0382-z","volume":"23","author":"M.W. Saif","year":"2008","unstructured":"Saif MW, Hashmi S, Zelterman D, et al. Capecitabine vs continuous infusion 5-FU in neoadjuvant treatment of rectal cancer. A retrospective review. Int J Colorectal Dis 2008;23:139\u201345.","journal-title":"Int J Colorectal Dis"},{"key":"2037_CR26","doi-asserted-by":"publisher","first-page":"1731","DOI":"10.1056\/NEJMoa040694","volume":"351","author":"R. Sauer","year":"2004","unstructured":"Sauer R, Becker H, Hohenberger W, et al. Preoperative versus postoperative chemoradiotherapy for rectal cancer. N Engl J Med 2004;351:1731\u201340.","journal-title":"N Engl J Med"},{"key":"2037_CR27","volume-title":"TNM classification of malignant tumours","author":"L.H. Sobin","year":"2002","unstructured":"Sobin LH, Wittekind C. TNM classification of malignant tumours, 6th edn. New York-Toronto: Wiley-Liss, 2002.","edition":"6th edn."},{"key":"2037_CR28","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1007\/s00066-007-1683-4","volume":"183","author":"H. Strasser","year":"2007","unstructured":"Strasser H, Grabenbauer GG, Sprung CN, et al. DNA double-strand break induction and repair in irradiated lymphoblastoid, fibroblast cell lines and white blood cells from ATM, NBS and radiosensitive patients. Strahlenther Onkol 2007;183:447\u201353.","journal-title":"Strahlenther Onkol"},{"key":"2037_CR29","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/S0360-3016(99)00559-3","volume":"47","author":"A. Trotti","year":"2000","unstructured":"Trotti A, Byhardt R, Stetz J, et al. Common toxicity criteria: version 2.0. An improved reference for grading the acute effects of cancer treatment: impact on radiotherapy. Int J Radiat Oncol Biol Phys 2000;47:13\u201347.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2037_CR30","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1007\/s00066-008-1858-7","volume":"184","author":"R.F. Vliegen","year":"2008","unstructured":"Vliegen RF, Beets-Tan RG, Vanhauten B, et al. Can an FDG-PET\/CT predict tumor clearance of the mesorectal fascia after preoperative chemoradiation of locally advanced rectal cancer? Strahlenther Onkol 2008;184:457\u201364.","journal-title":"Strahlenther Onkol"},{"key":"2037_CR31","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1007\/s00066-009-1928-5","volume":"185","author":"H. Vorwerk","year":"2010","unstructured":"Vorwerk H, Liersch T, Rothe H, et al. Gold markers for tumor localization and target volume delineation in radiotherapy for rectal cancer. Strahlenther Onkol 2010;185:127\u201333.","journal-title":"Strahlenther Onkol"}],"container-title":["Strahlentherapie und Onkologie"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00066-009-2037-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00066-009-2037-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00066-009-2037-1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00066-009-2037-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,25]],"date-time":"2019-05-25T00:55:56Z","timestamp":1558745756000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00066-009-2037-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,12,28]]},"references-count":31,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2010,1]]}},"alternative-id":["2037"],"URL":"https:\/\/doi.org\/10.1007\/s00066-009-2037-1","relation":{},"ISSN":["0179-7158","1439-099X"],"issn-type":[{"value":"0179-7158","type":"print"},{"value":"1439-099X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,12,28]]}}}